The opioid epidemic continues as one of America’s greatest public health crises as healthcare officials, public officials and countless Americans struggle to prevent opioid abuse, addiction and death. In a blog from 2017, Laurie Sullivan explores how one solution, known as The Smart Pill Drug Delivery Device, could be used to curb the crisis. Another possible solution? Prescribing more non-opioid painkillers. Click here to be notified when the BCC Research report “Non-opioid Pain Treatment: Global Markets to 2022” publishes later this month.
Smart pills are increasingly influencing our health. They are noninvasive and have redefined diagnosis, disease monitoring, and treatment adherence. By 2021, US sales of smart pills may double, reaching $1.2 billion. The global market for smart pills is poised to exceed a 20% compound annual growth rate (CAGR) during the next five years, according to BCC Research’s recent study, Smart Pills: Applications and Global Markets. High-growth application areas include capsule endoscopy, patient monitoring, and delivery of therapeutic agents. The adoption of advanced ingestible medical sensor technologies is a key growth driver.